Cytek Biosciences (CTKB) Acquisitions (2023 - 2024)
Cytek Biosciences (CTKB) reported Acquisitions of $471000.0 for Q4 2024, up 47000.0% quarter-over-quarter from $1000.0 in Q3 2023.
Cytek Biosciences (CTKB) Acquisitions (2023 - 2024) Analysis & Trends
Cytek Biosciences has reported Acquisitions for 2 years, with the latest figure at $471000.0 in Q4 2024.
- For the quarter ending Q4 2024, Acquisitions changed N/A year-over-year to $471000.0; the trailing twelve-month figure through Dec 2024 stood at $471000.0 (down 98.95% YoY), and the FY2024 full-year result was $471000.0, down 98.95% from the prior year.
- Acquisitions for Q4 2024 stood at $471000.0, up from $1000.0 in the prior quarter.
- The five-year high for Acquisitions was $44.9 million in Q1 2023, with the low at $1000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -268.10 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 471,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 44.90 Mn |